Skip to main content
. Author manuscript; available in PMC: 2009 Feb 1.
Published in final edited form as: Cancer Res. 2008 Feb 1;68(3):918–926. doi: 10.1158/0008-5472.CAN-07-5714

Figure 5.

Figure 5

Protein lysates from BxPC3 cells treated with HPSC-CM (1 μg/μL) were analyzed for Erk1/2 and Akt activation by Western blotting at various time points (A) and quantifed by densitometry. Control cells were treated with serum-free media alone. B, change in levels of phosphorylated Erk1/2 and Akt was compared with serum-free controls.